抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
LGX 818，99% | C22H27ClFN7O4S | |||
|
|
|||||
|
WAY-313218，97% | C19H20FNO | |||
|
|
|||||
|
MRTX0902，98% | C22H24N6O | |||
|
|
|||||
|
MK-2 Inhibitor III，98% | C21H18N4O2 | |||
|
|
|||||
|
Remdesivir O-desphosphate acetonide impurity，98% | C15H17N5O4 | |||
|
|
|||||
|
ASTX029，98% | C29H31ClFN5O5 | |||
|
|
|||||
|
PLX-4720，99% | C17H14ClF2N3O3S | |||
|
|
|||||
|
AL 8697，98% | C21H21F3N4O | |||
|
|
|||||
|
HPK1-IN-4，98% | C23H26N6O3 | |||
|
|
|||||
|
LJI308，99% | C21H18F2N2O2 | |||
|
|
|||||
|
EB1，98% | C18H14N4 | |||
|
|
|||||
|
Z16078526，98% | C18H17N3O4S | |||
|
|
|||||
|
Nek2-IN-5，95% | C15H12N6O | |||
|
|
|||||
|
Uplarafenib，98% | C22H21F3N4O4S | |||
|
|
|||||
